NSAIDs in Sciatica NSAIDS IN SCIATICA (NIS)

STATUS

Recruiting
End date

Nov 13, 2024
participants needed

150
sponsor

Ostfold Hospital Trust

Send

Updated on 13 May 2022

See if I qualify

weakness

NSAID

leg pain

paresthesia

numbness

radiating pain

Summary

This study will evaluate whether treatment with Naproxen 500 mg twice daily is superior to placebo for the improvement of leg pain in patients with sciatica. Half of patients will receive Naproxen while the other half will receive placebo.

Description

Sciatica is an established term for pain radiating from the lower back or buttock into the leg, commonly caused by a disc herniation. Given their analgesic and anti-inflammatory mechanisms of action, NSAIDs (Non-steroidal anti-inflammatory drugs) have been, and are still being regarded as standard therapy for sciatica.

However, very few randomised controlled trials of NSAIDs have been undertaken in sciatica, and no study has showed clinically meaningful effects as compared to placebo.

Since NSAIDs involve the risk of serious gastrointestinal, vascular and renal side effects there is a strong need to clarify their potential beneficial effects in sciatica.

Details

Condition	Sciatica
Treatment	Placebo, Naproxen 500 Mg
Clinical Study Identifier	NCT03347929
Sponsor	Ostfold Hospital Trust
Last Modified on	13 May 2022

How understandable was the trial content above?

Hard to understand

Easy to understand

Eligibility		Yes	No	Not Sure
Inclusion Criteria
	Age ≥ 18 years
	Radiating pain below the knee with a severity score of ≥4 on a 0-10 (NRS) in the previous 24 hours
	Signs of nerve root/spinal nerve involvement as indicated by at least one of the following features; myotomal weakness, dermatomal sensory disturbances (e.g. sensory loss, self-reported tingling/numbness), diminished reflexes, radiating pain exacerbation by SLR
Exclusion Criteria
	Not able to read or speak Norwegian
	Unlikely to adhere to treatment and/ or complete follow-up (e.g ongoing serious psychiatric disease, drug abuse, plans to move)
	Sciatica of known cause other than disc herniation or degenerative stenosis
	Neurogenic claudication, i.e. pain in the legs on walking or standing that resolves with sitting down or lumbar flexion
	Symptoms indicating immediate surgery: cauda equina syndrome or a progressive large paresis
	Women who attempt to conceive, are pregnant or breastfeeding
	Previous episodes of asthma, urticaria or allergic-type reactions after taking aspirin or other NSAIDs
	Active or history of peptic ulceration, gastrointestinal bleeding, or perforation
	Use of drugs known to increase upper gastrointestinal adverse events in combination with Naproxen: anticoagulants, aspirin (acetyl salicylic acid), serotonin reuptake inhibitors and systemic corticosteroids
	Hepatic enzyme (ASAT/ALAT) values above 1,5 x upper limit of normal (ULN)
	Renal function tests (creatinin/eGFR) outside normal range
	Congestive heart failure, established ischaemic heart disease, peripheral arterial disease, and/or cerebrovascular disease
	Known hypersensitivity to Naproxen or any of the excipients (lactose, maize starch, povidone, sodium starch glycolate, talcum, magnesium stearate, polysorbate 80)
	Ongoing treatment with aspirin, systemic corticosteroids, diuretics, ACE-inhibitors, lithium and anticoagulants
	Scheduled for spinal surgery prior to end of study
	Reservation against intake of gelatine (the capsules contains gelatine, which among other things is produced by ingredients from pigs)

How to participate?

Step 1 Connect with a study center

Select a site
Send a message

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Primary Contact

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Step 2 Get screened

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

Step 3 Enroll in the clinical study

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Step 4 Get your study results

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Edit Delete

Added by •

•

Private

Edit Delete

Reply by • • Private

Edit Delete

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

Enter the passcode

The passcode will expire in None.

NSAIDs in Sciatica NSAIDS IN SCIATICA (NIS)